Duration: (29:38) ?Subscribe5835 2025-02-11T07:54:14+00:00
Treatment Options for Diffuse Large B-Cell Lymphoma (DLBCL)
(5:26)
Relapsed and Refractory Diffuse Large B-Cell Lymphoma
(46:48)
First- and second-line treatment in DLBCL
(4:1econd)
Diffuse Large B-Cell Lymphoma (DLBCL) - Aggressive B-Cell Neoplasm - Non-Hodgkin’s Lymphoma
(8:21)
Initial Steps for Treatment of DLBCL
(1:55)
Treatment options for DLBCL
(54:13)
DLBCL in 2023: Top Docs Discuss the LATEST in Diffuse Large B-Cell Lymphoma | Treatments \u0026 Research
(29:)
The need for new treatment strategies for patients with DLBCL
(1:56)
The current state of treatment for limited-stage DLBCL
(1:31)
Treatment of Newly Diagnosed DLBCL
(5:44)
What Are Common Side Effects of DLBCL Treatment?
Managing early \u0026 late relapse after first-line therapy for DLBCL
(1:39)
Advancements in the DLBCL treatment landscape
(46)
Diffuse large B-cell lymphoma diagnosis and treatment
(1:46)
How to treat Diffuse Large B-Cell Lymphoma (DLBCL) - Dr. Carla Casulo
(24:57)
The need for more effective, less toxic therapies in frontline DLBCL treatment
(2:18)
Advances and unmet needs in second-line treatment of DLBCL
(1:34)
DLBCL Treatment Approaches: What You Need to Know
(29:38)
ViPOR: a multi-targeted therapy for the treatment of R/R DLBCL
(2:15)